Morgan Joseph
-
Morgan Joseph Reiterates a 'Buy' on ImmunoGen (IMGN); Expect Larger T-DM1 Contribution
-
Notable Analyst Rating Changes 8/4: CX, NEU, CHK, AKAM Upgraded; DE, AKS, ESRX, ELN Downgraded
-
Morgan Joseph Initiates Immunogenic (IMGN) with a Buy
